Fortrea
Pamela Jasperse currently serves as the Executive Strategic Partnerships Director at Fortrea since June 2023, where responsibilities include managing the client portfolio and supporting Molecule to Market initiatives. Prior to this role, Pamela held various executive positions at Labcorp Drug Development from October 2018 to June 2023, including Executive Director of Partnership Solutions and Drug Development Partnership Solutions. Pamela also contributed significantly to project management at Chiltern from January 2009 to October 2018, where responsibilities encompassed team management, operational accountability, and standard setting across project management functions. Earlier career experiences include roles at Covance, AstraZeneca, ClinTec International, and Quintiles, with a focus on clinical project management and clinical research. Pamela earned a Bachelor of Science degree in Biology from The University of Edinburgh from 1992 to 1996.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.